Renfu Pharmaceutical (600079.SH) RFUS-949 tablets approved for clinical trials

Zhitongcaijing · 05/29/2025 08:09

Zhitong Finance App News, Renfu Pharmaceutical (600079.SH) announced that Yichang Renfu Pharmaceutical Co., Ltd. (“Yichang Renfu”), a holding subsidiary of the company, recently received the RFUS-949 “Drug Clinical Trial Approval Notice” approved and issued by the State Drug Administration, agreeing to carry out clinical trials of this product for acute and chronic pain.